International Business News - IOMI http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biotechnology company Iomai Corp. said Friday its shareholders approved the company's sale to a unit of vaccine maker Intercell AG. Intercell offered to buy the Gaithersburg, Md., company in May for $189 million, or $6.60 per share, in cash and stock. Iomai says shareholders owning approximately 71.6 percent of its stock voted in favor of the deal, which is expected to close Tuesday. http://www.ibtimes.com/articles/20080801/iomai-shareholders-approve-sale-to-intercell.htm Fri, 01 Aug 2008 12:02:27 EDT Shares of Iomai Corp. surged Tuesday after the biotechnology company said vaccine maker Intercell AG offered a buyout deal of $189 million, a sharp premium for the shares. http://www.ibtimes.com/articles/20080513/iomai-shares-surge-on-premium-buyout-offer.htm Tue, 13 May 2008 17:25:44 EDT Biotechnology company Iomai Corp. said late Monday it is being bought by vaccine developer Intercell AG for about $189 million, as part of that company's effort to expand its late-stage pipeline. http://www.ibtimes.com/articles/20080513/iomai-being-acquired-by-vaccine-maker-intercell.htm Tue, 13 May 2008 07:56:20 EDT Iomai Corp., a vaccine research company, said Thursday it will conduct preclinical trials with Merck & Co. to review uses for its patch which stimulates the immune system. The deal gives drugmaker M... http://www.ibtimes.com/articles/20080403/iomai-merck-to-test-immune-boost-patch.htm Thu, 03 Apr 2008 08:19:12 EDT